US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
US8003595B2
(en)
|
2000-03-01 |
2011-08-23 |
Cellectis |
Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
|
CA2406839C
(en)
*
|
2000-04-21 |
2013-06-11 |
Athan Kuliopulos |
G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
|
US7696168B2
(en)
|
2000-04-21 |
2010-04-13 |
Tufts Medical Center, Inc. |
G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
|
GB0313132D0
(en)
*
|
2003-06-06 |
2003-07-09 |
Ich Productions Ltd |
Peptide ligands
|
WO2005018650A2
(fr)
|
2003-08-14 |
2005-03-03 |
Diatos |
Composition anti-bacterienne plus particulierement contre les bacteries gram negatif comprenent un peptide et un agent anti-bacterien avantageusement hydrophobe
|
EP1512696A1
(de)
*
|
2003-08-14 |
2005-03-09 |
Diatos |
Aminsäuresequenz, die den Transfer von Substanzen von Interesse in das Innere von Zellen und/oder Zellkernen erleichtern
|
CN107090025A
(zh)
|
2003-11-05 |
2017-08-25 |
达纳-法伯癌症研究所股份有限公司 |
稳定的α螺旋肽及其用途
|
US20060040882A1
(en)
|
2004-05-04 |
2006-02-23 |
Lishan Chen |
Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
WO2005117991A2
(en)
*
|
2004-05-04 |
2005-12-15 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
EP1809291A4
(de)
*
|
2004-11-03 |
2012-04-04 |
Forhumantech Co Ltd |
Pharmazeutische zusammensetzungen für transdermale abgabe
|
BRPI0517058A
(pt)
*
|
2004-11-04 |
2008-09-30 |
New England Medical Center Inc |
agonistas e antagonistas do receptor acoplado à proteìna g e métodos de uso
|
FR2877946B1
(fr)
|
2004-11-12 |
2011-02-11 |
Commissariat Energie Atomique |
Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet
|
US7741275B2
(en)
|
2004-12-22 |
2010-06-22 |
Lipopeptide Ab |
Agents and use thereof
|
EP1846014B1
(de)
|
2005-01-18 |
2012-10-24 |
The Board of Governors for Higher Education State of Rhode Island and Providence Plantations |
Selektive molekülabgabe in zellen oder markierung von zellen in erkrankten geweberegionen unter verwendung eines umgebungssensitiven transmembranpeptids
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
PL2236608T3
(pl)
|
2005-10-04 |
2017-06-30 |
Soligenix, Inc. |
Nowe peptydy do leczenia i profilaktyki zaburzeń immuno-zależnych w tym do leczenia i profilaktyki zakażenia przez modulację odporności wrodzonej
|
WO2007105565A1
(ja)
*
|
2006-03-13 |
2007-09-20 |
Keio University |
インフルエンザ感染阻害ペプチド、インフルエンザウイルス感染阻害剤、リポソーム、インフルエンザ予防・治療剤
|
WO2008063315A2
(en)
*
|
2006-10-13 |
2008-05-29 |
University Of Southern California |
C-TERMINAL DOMAIN TRUNCATION OF MGLUR1α BY CALPAIN AND USES THEREOF
|
EP2980219B1
(de)
*
|
2006-12-28 |
2018-11-14 |
International Institute of Cancer Immunology, Inc. |
Hla-a*1101-beschränktes wt1-peptid und pharmazeutische zusammensetzung damit
|
CA2676797C
(en)
*
|
2007-01-29 |
2014-04-22 |
Dae Woong Jo |
Novel macromolecule transduction domains and methods for identification and uses thereof
|
CA2677045C
(en)
|
2007-01-31 |
2016-10-18 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
DE102007008596B4
(de)
*
|
2007-02-15 |
2010-09-02 |
Friedrich-Schiller-Universität Jena |
Biologisch wirksame Moleküle auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung
|
CA2682174C
(en)
|
2007-03-28 |
2021-04-06 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
WO2009009441A2
(en)
|
2007-07-06 |
2009-01-15 |
Cedars-Sinai Medical Center |
Self-assembling complex for targeting chemical agents to cells
|
JP2010537632A
(ja)
*
|
2007-08-29 |
2010-12-09 |
タフツ ユニバーシティー |
組織及び細胞への核酸、タンパク質、薬物、及びアデノウイルスの送達を向上させるための細胞透過性ペプチドの製造及び使用方法、組成物並びにキット
|
WO2009041902A1
(en)
*
|
2007-09-25 |
2009-04-02 |
Loefgren Kajsa |
Prion protein derived cell penetrating peptides and their uses
|
TW200932260A
(en)
*
|
2007-11-28 |
2009-08-01 |
Oncotherapy Science Inc |
STAT3 epitope peptides
|
KR20100126361A
(ko)
|
2008-02-08 |
2010-12-01 |
에일러론 테라퓨틱스 인코포레이티드 |
치료용 펩티드유사 거대고리
|
DE102009043743B4
(de)
|
2009-03-13 |
2016-10-13 |
Friedrich-Schiller-Universität Jena |
Zellspezifisch wirksame Moleküle auf Grundlage von siRNA sowie Applikationskits zu deren Herstellung und Verwendung
|
EP2090584A1
(de)
|
2008-02-13 |
2009-08-19 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Identifikation eines neuartigen Zystein-reichen Peptids zur Zellenpenetration
|
CN102016058A
(zh)
*
|
2008-02-21 |
2011-04-13 |
伯纳姆医学研究所 |
与具有c端元件的肽和蛋白相关的方法和组合物
|
GB0804496D0
(en)
|
2008-03-11 |
2008-04-16 |
Theryte Ltd |
Treating cancer
|
US20110195911A1
(en)
*
|
2008-03-28 |
2011-08-11 |
The United States Of America,As Represented By The Secretary,Department Of Health & Human Services |
Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof
|
WO2009137689A2
(en)
*
|
2008-05-07 |
2009-11-12 |
Surmodics, Inc. |
Delivery of nucleic acid complexes from particles
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
WO2009149214A2
(en)
*
|
2008-06-03 |
2009-12-10 |
Aileron Therapeutics, Inc. |
Compositions and methods for enhancing cellular transport of biomolecules
|
WO2009147368A1
(en)
*
|
2008-06-04 |
2009-12-10 |
Medical Research Council |
Peptides
|
EP2294081B1
(de)
|
2008-06-12 |
2016-12-14 |
Centre For Addiction And Mental Health |
Zusammensetzungen und verfahren zur modulierung der d1-d2-dopaminrezeptorinteraktion und -funktion
|
US20110218334A1
(en)
*
|
2008-07-11 |
2011-09-08 |
Alnylam Pharmaceuticals, Inc. |
PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS
|
WO2010011313A2
(en)
|
2008-07-23 |
2010-01-28 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
CN104961795A
(zh)
|
2008-09-22 |
2015-10-07 |
爱勒让治疗公司 |
用于制备纯化的多肽组合物的方法
|
US20140248296A1
(en)
*
|
2008-10-16 |
2014-09-04 |
Kathleen Cogan Farinas |
Sustained drug delivery system
|
US20110294738A1
(en)
*
|
2008-11-04 |
2011-12-01 |
Yong Ren |
Pthr1 receptor compounds
|
WO2010053547A2
(en)
*
|
2008-11-04 |
2010-05-14 |
Anchor Therapeutics, Inc. |
Cxcr5 receptor compounds
|
WO2010072228A1
(en)
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
US20110258713A1
(en)
*
|
2008-12-23 |
2011-10-20 |
Vivoscript, Inc. |
Compositions and methods for re-programming cells without genetic modification
|
AU2010204648B2
(en)
|
2009-01-14 |
2016-09-01 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
WO2010085665A2
(en)
|
2009-01-23 |
2010-07-29 |
Cedars-Sinai Medical Center |
Targeted delivery system
|
JP5616428B2
(ja)
|
2009-04-07 |
2014-10-29 |
ロシュ グリクアート アクチェンゲゼルシャフト |
三価の二重特異性抗体
|
CA2756927A1
(en)
*
|
2009-04-09 |
2010-10-14 |
Centre For Addiction And Mental Health |
Dopamine d2 receptor-disc1 interaction, compositions and methods for modulating same
|
US9676845B2
(en)
|
2009-06-16 |
2017-06-13 |
Hoffmann-La Roche, Inc. |
Bispecific antigen binding proteins
|
GB0910620D0
(en)
|
2009-06-19 |
2009-08-05 |
Immunovia Ab |
Agents and uses thereof
|
EP2445536B1
(de)
|
2009-06-22 |
2016-06-08 |
Burnham Institute for Medical Research |
Verfahren und zusammensetzungen mit peptiden und proteinen mit c-terminalen elementen
|
WO2011008260A2
(en)
|
2009-07-13 |
2011-01-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
CN102712675A
(zh)
|
2009-09-22 |
2012-10-03 |
爱勒让治疗公司 |
拟肽大环化合物
|
WO2011038002A1
(en)
*
|
2009-09-22 |
2011-03-31 |
Yale University |
Immunogenic epitopes as targets for universal cancer vaccines
|
EP4089169A1
(de)
|
2009-10-12 |
2022-11-16 |
Larry J. Smith |
Verfahren und zusammensetzungen zum modulieren der genexpression mit in-vivo oder in-vitro verabreichten arzneistoffen auf oligonukleotidbasis
|
WO2011072292A2
(en)
*
|
2009-12-11 |
2011-06-16 |
Dicerna Pharmaceuticals, Inc. |
Phase changing formulations of rna and rna derivatives
|
US20110159098A1
(en)
*
|
2009-12-30 |
2011-06-30 |
Surmodics, Inc. |
Stabilization and delivery of nucleic acid complexes
|
US8980253B2
(en)
|
2010-04-26 |
2015-03-17 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
|
CN103096911B
(zh)
|
2010-04-27 |
2018-05-29 |
Atyr 医药公司 |
与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
AU2011248489B2
(en)
|
2010-04-28 |
2016-10-06 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases
|
EP2563383B1
(de)
|
2010-04-29 |
2017-03-01 |
Atyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von valyl-trna-synthetasen
|
WO2011150279A2
(en)
|
2010-05-27 |
2011-12-01 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
|
CN103097523B
(zh)
|
2010-04-29 |
2016-09-28 |
Atyr医药公司 |
与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
US9034321B2
(en)
|
2010-05-03 |
2015-05-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
|
CA2797277C
(en)
|
2010-05-03 |
2021-02-23 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
|
EP2566496B1
(de)
|
2010-05-03 |
2018-02-28 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von methionyl-trna-synthetasen
|
CA2798139C
(en)
|
2010-05-04 |
2019-09-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
|
CN103200953B
(zh)
|
2010-05-14 |
2017-02-15 |
Atyr 医药公司 |
与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
AU2011261486B2
(en)
|
2010-06-01 |
2017-02-23 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases
|
US9540680B2
(en)
*
|
2010-06-07 |
2017-01-10 |
The Trustees Of The University Of Pennsylvania |
Transcriptome in vivo analysis
|
WO2011157713A2
(en)
|
2010-06-14 |
2011-12-22 |
F. Hoffmann-La Roche Ag |
Cell-penetrating peptides and uses therof
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
US20130097717A1
(en)
*
|
2010-06-23 |
2013-04-18 |
Vivoscript, Inc. |
Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases
|
EP2593125B1
(de)
|
2010-07-12 |
2017-11-01 |
aTyr Pharma, Inc. |
Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von glycyl-trna-synthetasen
|
US8791121B2
(en)
|
2010-08-12 |
2014-07-29 |
New York University |
Oligooxopiperazines and methods of making and using them
|
WO2012021876A2
(en)
|
2010-08-13 |
2012-02-16 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2807278A1
(en)
|
2010-08-24 |
2012-03-01 |
F. Hoffmann - La Roche Ag |
Bispecific antibodies comprising a disulfide stabilized - fv fragment
|
JP5753903B2
(ja)
*
|
2010-08-24 |
2015-07-22 |
ロシュ グリクアート アーゲー |
活性化可能な二重特異性抗体
|
CN103108650A
(zh)
|
2010-08-25 |
2013-05-15 |
Atyr医药公司 |
与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
WO2012048721A1
(en)
|
2010-10-14 |
2012-04-19 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
WO2012078734A2
(en)
*
|
2010-12-08 |
2012-06-14 |
The Research Foundation Of State University Of New York |
Polypeptide derived from calcitonin receptors and methods of use
|
WO2012090150A2
(en)
|
2010-12-27 |
2012-07-05 |
Compugen Ltd |
New cell-penetrating peptides and uses thereof
|
US8901092B2
(en)
|
2010-12-29 |
2014-12-02 |
Surmodics, Inc. |
Functionalized polysaccharides for active agent delivery
|
MX341921B
(es)
|
2011-02-28 |
2016-09-07 |
Hoffmann La Roche |
Proteinas de union a antigeno.
|
WO2012118778A1
(en)
|
2011-02-28 |
2012-09-07 |
Sanford-Burnham Medical Research Institute |
Truncated car peptides and methods and compositions using truncated car peptides
|
CA2824824A1
(en)
|
2011-02-28 |
2012-09-07 |
F. Hoffmann-La Roche Ag |
Monovalent antigen binding proteins
|
JP6225104B2
(ja)
|
2011-04-08 |
2017-11-01 |
タフツ メディカル センター インコーポレイテッドTufts Medical Center,Inc. |
ペプデューシンの設計および使用
|
EP2714971A4
(de)
*
|
2011-05-23 |
2015-01-21 |
Phylogica Ltd |
Verfahren zur bestimmung, identifizierung und isolierung zellpenetrierender peptide
|
WO2012166585A2
(en)
|
2011-05-31 |
2012-12-06 |
Airware, Inc. |
Re-calibration of ab ndir gas sensors
|
WO2012174423A1
(en)
|
2011-06-17 |
2012-12-20 |
President And Fellows Of Harvard College |
Stabilized polypeptides as regulators of rab gtpase function
|
EP2537858A1
(de)
|
2011-06-20 |
2012-12-26 |
Commissariat à l'Énergie Atomique et aux Énergies Alternatives |
Kleine effiziente zelleindringende Peptide aus dem Skorpiongift Maurocalcin
|
US10179801B2
(en)
|
2011-08-26 |
2019-01-15 |
Sanford-Burnham Medical Research Institute |
Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
|
IN2014MN00357A
(de)
|
2011-08-30 |
2015-06-19 |
Medical Res Council |
|
EP2755679B1
(de)
*
|
2011-09-13 |
2017-08-02 |
Immunotope, Inc. |
Zytotoxische t-lymphozyten-induzierende immunogene zur prävention, behandlung und diagnose von krebs
|
CN108929375A
(zh)
|
2011-10-18 |
2018-12-04 |
爱勒让治疗公司 |
拟肽大环化合物
|
CN110251682B
(zh)
|
2011-11-24 |
2022-12-06 |
苏州宝时得电动工具有限公司 |
多肽序列设计及其在多肽介导的siRNA传递中的应用
|
CN102532565B
(zh)
*
|
2011-12-19 |
2013-08-28 |
上海交通大学 |
可降解亚胺类聚阳离子及其合成方法、纳米颗粒
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
WO2013123267A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
ES2817877T3
(es)
|
2012-02-15 |
2021-04-08 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos
|
CN104334541A
(zh)
|
2012-02-16 |
2015-02-04 |
纽约大学 |
使用低聚氧代哌嗪非肽螺旋模拟物对低氧诱导基因表达的控制
|
EP2864348A2
(de)
*
|
2012-06-26 |
2015-04-29 |
F. Hoffmann-La Roche AG |
Zellpenetrierende peptide und verfahren zur identifikation zellpenetrierende peptide
|
ES2703052T3
(es)
|
2012-08-03 |
2019-03-06 |
Cedars Sinai Medical Center |
Aislamiento de mutantes potenciadores del tráfico de proteína de entrega de fármacos
|
EP2708235A1
(de)
|
2012-09-17 |
2014-03-19 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
Peptidantagonisten des Vasopressin-2-Rezeptors
|
EP2920197B1
(de)
|
2012-09-26 |
2021-03-17 |
President and Fellows of Harvard College |
Prolinblockierte geheftete peptide und verwendungen davon
|
JP6526563B2
(ja)
|
2012-11-01 |
2019-06-05 |
エイルロン セラピューティクス,インコーポレイテッド |
二置換アミノ酸ならびにその調製および使用の方法
|
CN105008396A
(zh)
|
2012-11-25 |
2015-10-28 |
加利福尼亚大学董事会 |
刺激皮下脂肪形成的肽
|
ITMI20122263A1
(it)
*
|
2012-12-28 |
2014-06-29 |
Azienda Ospedaliero Universitaria Di Parma |
Nuovi peptidi cationici ciclici ad attività antimicrobica
|
US10081654B2
(en)
|
2013-03-13 |
2018-09-25 |
President And Fellows Of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
AU2014240783B2
(en)
|
2013-03-28 |
2019-02-14 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
New uranium-chelating peptides derived from EF-hand calcium-binding motif useful for uranium biodetection and biodecontamination
|
EP2784094A1
(de)
|
2013-03-28 |
2014-10-01 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
Neue uranchelatisierende, vom EF-Hand-Calciumsbindungsmotiv abgeleitete Peptide zur Uran-Biodetektion und -Biodekontamination
|
CN105492460A
(zh)
|
2013-06-14 |
2016-04-13 |
哈佛大学的校长及成员们 |
稳定化多肽胰岛素受体调控剂
|
WO2015197097A1
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
US20160146786A1
(en)
*
|
2013-06-26 |
2016-05-26 |
Phylogica Limited |
Method of monitoring cellular trafficking of peptides
|
CA2903275A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
EP2842566A1
(de)
|
2013-09-03 |
2015-03-04 |
Centre National De La Recherche Scientifique |
Verwendung von Arpin als neuer Hemmer des ARP2/3-Komplexes zur Diagnose und Behandlung von Krankheiten
|
BR112016006929A2
(pt)
|
2013-10-11 |
2017-09-19 |
Hoffmann La Roche |
Anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, métodos de preparação de anticorpo, de tratamento de pacientes e de geração de um anticorpo, composição farmacêutica e uso do anticorpo
|
JP6493216B2
(ja)
*
|
2013-11-05 |
2019-04-03 |
味の素株式会社 |
ペプチドヒドラジド、ペプチドアミド及びペプチドチオエステルの製造方法
|
WO2015097267A1
(en)
*
|
2013-12-23 |
2015-07-02 |
Covalab |
mTG SUBSTRATES FOR COVALENT CONJUGATION OF COMPOUNDS
|
WO2015105957A1
(en)
*
|
2014-01-08 |
2015-07-16 |
Shriners Hospitals For Children |
Pten antagonist peptides and methods of using the same
|
US10682388B2
(en)
*
|
2014-01-15 |
2020-06-16 |
The Board Of Regents Of The University Of Texas System |
Targeting of PELP1 in cancer therapy
|
MX2016009284A
(es)
|
2014-01-17 |
2016-10-07 |
Cedars Sinai Medical Center |
Construcciones dirigidas a receptor y sus usos.
|
EP2905031A1
(de)
|
2014-02-10 |
2015-08-12 |
B Cell Design |
Neues, nicht-HIV-Impfstoff-Antigen aus der vaginalen Mikrobiota zur Induzierung einer mukosalen, neutralisierenden, schützenden Antikörperreaktion gegen eine HIV-Infektion
|
MX2016013025A
(es)
|
2014-04-04 |
2017-04-27 |
Cedars Sinai Medical Center |
Focalizacion de cancer de mama her2+ resistente a trastuzumab con una nanoparticula dirigida de her3.
|
AU2015264122B2
(en)
|
2014-05-21 |
2021-02-04 |
President And Fellows Of Harvard College |
Ras inhibitory peptides and uses thereof
|
US10844102B2
(en)
|
2014-05-28 |
2020-11-24 |
The Regents Of The University Of California |
Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
|
SG10201902594QA
(en)
|
2014-09-24 |
2019-04-29 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and uses thereof
|
BR112017005736A2
(pt)
|
2014-09-24 |
2017-12-12 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos e formulações dos mesmos
|
WO2016087416A1
(en)
|
2014-12-03 |
2016-06-09 |
F. Hoffmann-La Roche Ag |
Multispecific antibodies
|
CA2979847A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
CN109265517B
(zh)
|
2015-03-27 |
2024-05-10 |
伊玛提克斯生物技术有限公司 |
用于各种肿瘤免疫治疗的肽和肽组合物
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
US9795624B2
(en)
|
2015-05-04 |
2017-10-24 |
Research Foundation Of The City University Of New York |
Cationic polymers as co-drugs for chemotherapeutic agents
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CN108368161A
(zh)
|
2015-09-10 |
2018-08-03 |
艾瑞朗医疗公司 |
作为mcl-1调节剂的拟肽大环化合物
|
WO2017083618A1
(en)
|
2015-11-13 |
2017-05-18 |
Oasis Pharmaceuticals, LLC |
Protease-activated receptor-2 modulators
|
US10639348B2
(en)
|
2016-03-15 |
2020-05-05 |
Idp Discovery Pharma, S.L. |
Peptides with anti-cancer activity
|
GB201607521D0
(en)
*
|
2016-04-29 |
2016-06-15 |
Oncolmmunity As |
Method
|
WO2018013912A1
(en)
*
|
2016-07-15 |
2018-01-18 |
The Board Of Regents Of The University Of Oklahoma |
Anti-arid3a treatments for inflammatory disorders
|
GB201618432D0
(en)
|
2016-11-01 |
2016-12-14 |
Matn Scient Ltd |
Detection and treatment of demyelinating diseases
|
TWI781963B
(zh)
|
2016-11-09 |
2022-11-01 |
俄亥俄州立創新基金會 |
含二硫化物細胞穿透肽及其製造與使用方法
|
US11352394B2
(en)
|
2016-11-22 |
2022-06-07 |
Ohio State Innovation Foundation |
Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
|
IL302130A
(en)
|
2016-12-07 |
2023-06-01 |
Molecular Templates Inc |
Shiga toxin A subunit activator polypeptides, Shiga toxin activator scaffolds and cell-targeting molecules for site-specific conjugation
|
EP3360891B1
(de)
|
2017-02-14 |
2022-03-30 |
Karlsruher Institut für Technologie |
Zellenpenetrierende peptide menschlichen ursprungs
|
WO2018204392A1
(en)
|
2017-05-02 |
2018-11-08 |
Stanford Burnham Prebys Medical Discovery Institute |
Tumor associated monocyte/macrophage binding peptide and methods of use thereof
|
KR102095284B1
(ko)
*
|
2017-05-11 |
2020-04-01 |
(주)케어젠 |
메토트렉세이트와 펩타이드의 결합체
|
EP3654941A1
(de)
|
2017-07-17 |
2020-05-27 |
Keith Roizman |
Topische verabreichung von therapeutischen mitteln mit zellpenetrierenden peptiden zur verwendung zur behandlung von altersbedingter makuladegeneration und anderen augenerkrankungen
|
US20200223894A1
(en)
*
|
2017-09-19 |
2020-07-16 |
Auckland Uniservices Limited |
Peptides for the treatment of conditions associated with adiponectin dysfunction
|
JP2021505138A
(ja)
*
|
2017-12-04 |
2021-02-18 |
ヒート バイオロジクス,インコーポレイテッド |
細胞に基づくワクチンの製造
|
US11987647B2
(en)
|
2018-05-09 |
2024-05-21 |
Ohio State Innovation Foundation |
Cyclic cell-penetrating peptides with one or more hydrophobic residues
|
KR102167755B1
(ko)
|
2018-05-23 |
2020-10-19 |
주식회사 큐어바이오 |
단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도
|
US20210244824A1
(en)
*
|
2018-07-02 |
2021-08-12 |
Ohio State Innovation Foundation |
Polypeptide conjugates for intracellular delivery of nucleic acids
|
JP7489319B2
(ja)
*
|
2018-09-26 |
2024-05-23 |
株式会社カネカ |
細胞膜透過性ペプチド
|
EP3890783A1
(de)
*
|
2018-12-07 |
2021-10-13 |
Oxford University Innovation Limited |
Linker
|
KR20210134651A
(ko)
*
|
2019-02-01 |
2021-11-10 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
폐로의 핵산 전달을 위한 희생 세포-침투 복합체
|
CA3127985A1
(en)
|
2019-02-04 |
2020-08-13 |
University Of Tartu |
Bi-specific extracellular matrix binding peptides and methods of use thereof
|
JP2022549057A
(ja)
|
2019-07-11 |
2022-11-24 |
厦▲門▼大学 |
分子の細胞内送達のための複合体
|
KR20230096914A
(ko)
*
|
2019-07-22 |
2023-06-30 |
원스킨 인크. |
항노화 효과를 갖는 폴리펩타이드 및 그의 용도
|
TW202120117A
(zh)
*
|
2019-08-02 |
2021-06-01 |
西班牙商Idp發現製藥公司 |
黑色素細胞調節胜肽
|
JP2023509666A
(ja)
|
2019-12-31 |
2023-03-09 |
シァメン・ユニヴァーシティ |
分子の細胞内送達用の多量体化送達システム
|
EP3906935A1
(de)
|
2020-05-06 |
2021-11-10 |
Sorbonne Universite |
Peptide zur vorbeugung oder behandlung viraler infektionen
|
CN113943778A
(zh)
*
|
2020-07-17 |
2022-01-18 |
通用电气医疗集团股份有限公司 |
用于核酸检测的分子探针及其制备方法和用途
|
CA3206148A1
(en)
|
2021-01-24 |
2022-07-28 |
Michael David FORREST |
Therapeutic modifiers of the reverse mode of atp synthase
|
US20240182526A1
(en)
*
|
2021-03-31 |
2024-06-06 |
University Of Southern California |
Compositions and methods for modulting inflammatory and degenerative disorder
|
JP2024513087A
(ja)
|
2021-04-07 |
2024-03-21 |
アストラゼネカ・アクチエボラーグ |
部位特異的改変のための組成物及び方法
|
KR102504190B1
(ko)
*
|
2021-06-03 |
2023-02-28 |
주식회사 레메디 |
화물분자 수송 도메인 rmmr1, 이의 변이체, 이를 포함하는 재조합 화물분자 및 이를 이용한 화물분자 수송 방법
|
CN114349846B
(zh)
*
|
2022-01-07 |
2023-12-15 |
天津市泌尿外科研究所 |
一种人精子膜蛋白or1d2特异性多肽与抗体的制备方法
|
WO2023181070A1
(en)
*
|
2022-03-23 |
2023-09-28 |
Council Of Scientific & Industrial Research |
PEPTIDE TO TREAT α-SYNUCLEIN AMYLOID BASED DISORDERS
|
CN116444678B
(zh)
*
|
2022-10-18 |
2024-02-02 |
百葵锐(深圳)生物科技有限公司 |
一种具有真菌抗菌抑菌性能的新型多肽
|
WO2024119101A1
(en)
|
2022-12-01 |
2024-06-06 |
Yale University |
Stimuli-responsive traceless engineering platform for intracellular payload delivery
|